From: Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers
Clinicopathologic factors | Number of sample |
---|---|
Age | |
Mean | 59 years |
range | 35-84 years |
Histology | |
Ductal | 28 |
Lobular | 4 |
Mixed | 4 |
Other | 2 |
Clinical stage | |
I | 0 |
II | 12 |
III | 17 |
IV | 9 |
Tumor size | |
< 2 cm | 11 |
> 2 cm | 27 |
Grade | |
I | 0 |
II | 16 |
III | 22 |
ER Status | |
Positive | 30 |
Negative | 8 |
PR status | |
Positive | 23 |
Negative | 15 |
HER-2/neu primary tumor | |
Positive | 10 |
Negative | 28 |
HER-2/neu lymph node metastasis | |
Positive | 11 |
Negative | 22 |
N/A | 5 |
Follow up status | |
Progression (recurrence, metastasis, death) | 14 |
No evidence of disease | 20 |
Lost to follow-up | 4 |